Venture tracks

David Wetherell and Douglas Lind joined the Burrill & Co. venture capital group as managing directors. Joshua Zelig joined as a director. Wetherell was founder of GBP Capital. Lind was a managing director at GBP, while Zelig was an associate partner at the firm.

Sandford Smith joined Tullis Health Investors as a managing director. He was EVP and president of the international group at Genzyme Corp., a subsidiary of Sanofi (Euronext:SAN; NYSE:SNY)...